Active specific immunotherapy with Newcastle-disease-virus-modified autologous tumor cells following resection of liver metastases in colorectal cancer. First evaluation of clinical response of a phase II-trial.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples